3-溴-2-甲基吲哚-1-羧酸叔丁酯 | 775305-12-9

• 物质功能分类: 医药中间体 - 吲哚类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 3-溴-2-甲基吲哚-1-羧酸叔丁酯
• 英文名称: tert-butyl 3-bromo-2-methyl-1H-indole-1-carboxylate
• 英文别名: tert-butyl 3-bromo-2-methyl-1H-indoie-1-carboxylate；tert-butyl 3-bromo-2-methylindole-1-carboxylate
• CAS: 775305-12-9
• 化学式: C₁₄H₁₆BrNO₂
• 分子量: 310.191
• InChiKey: RUAYZSFSPSZYHI-UHFFFAOYSA-N

物化性质

• 沸点：
  384.4±34.0 °C(Predicted)
• 密度：
  1.34±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  31.2
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2933990090
• 危险性防范说明：
  P280
• 危险性描述：
  H302,H317

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Bromo-2-methylindole-1-carboxylic acid tert-butyl ester
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Bromo-2-methylindole-1-carboxylic acid tert-butyl ester
CAS number: 775305-12-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C14H16BrNO2
Molecular weight: 310.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-溴-2-甲基吲哚-1-羧酸叔丁酯 在 四(三苯基膦)钯 sodium carbonate 、 三氟乙酸 作用下， 以 四氢呋喃 、 水 、 乙腈 为溶剂， 反应 7.58h， 生成 2-(3-(2-Benzyl-1-oxo-1,2-dihydroisoquinolin-4-yl)-2-methyl-1H-indol-1-yl)acetic acid
  参考文献：
  名称：

  INDOLE BASED RECEPTOR CRTH2 ANTAGONISTS

  摘要：

  公开的是以下化合物的结构（I）：这些化合物可用作CRTH2受体的拮抗剂。还公开了含有化合物（I）的药物组合物以及利用化合物（I）治疗对抑制内源配体与CRTH2受体结合响应的疾病或疾病的用途。进一步描述了制备和使用这些化合物的方法。

  公开号：

  US20110105509A1
• 作为产物：
  描述：

  tert-butyl 2-methyl-1H-indole-1-carboxylate 在 Oxone 、 potassium bromide 作用下， 以 乙腈 为溶剂， 以88 %的产率得到3-溴-2-甲基吲哚-1-羧酸叔丁酯
  参考文献：
  名称：

  吲哚与 Oxone-卤化物的绿色卤化

  摘要：

  吲哚的氧化官能化是开发吲哚合成效用的最广泛使用的方法之一。为了延续我们对吲哚绿色氧化的研究兴趣，我们进一步探索了吲哚与过氧化氢卤化物的氧化，发现吲哚氮上的保护基团在控制吲哚与过氧化氢卤化物氧化的途径中起着决定性作用。吲哚氮上的吸电子基团（N-EWG）可以用化学计量的卤化物进行C2卤化，而使用化学计量的卤化物可以选择性地实现C3卤化，而不依赖于吲哚氮上保护基团的电子性质。与我们之前使用催化卤化物获得的结果不同，这些发现导致开发出一种环境友好、高效且温和的方案来获取 2- 或 3- 卤代吲哚（氯代和溴代）。与之前的2-/3-卤代吲哚的合成方法相比，我们的方法利用过氧化氢卤化物中原位产生的反应性卤化物质来卤化吲哚，从而消除了化学计量卤化剂的使用以及有毒有害物质的产生。源自氧化剂的有机副产品。

  DOI：

  10.1021/acs.joc.3c00638

文献信息

• Sensitive Assays by Nucleophile-Induced Rearrangement of Photoactivated Diarylethenes
  作者：Sebastian Fredrich、Aurelio Bonasera、Virginia Valderrey、Stefan Hecht

  DOI：10.1021/jacs.8b02982

  日期：2018.5.23

  Upon light-induced isomerization, diarylethenes (DAEs) equipped with reactive aldehyde moieties rearrange selectively in the presence of amines, accompanied by decoloration. In a comprehensive study, the probe structure was optimized with regard to its inherent reactivity in the nucleophile-triggered rearrangement reaction. Detailed structure-reactivity relationships could be derived, in particular

  在光诱导异构化后，带有反应性醛部分的二芳基乙烯 (DAE) 在胺存在下选择性地重排，并伴有脱色。在一项综合研究中，探针结构根据其在亲核试剂触发的重排反应中的固有反应性进行了优化。可以推导出详细的结构-反应关系，特别是关于整合（杂）芳基部分的类型以及甲酰基残基的位置，并且优化了探针与伯胺和仲胺的固有反应性。利用辅助碱基，最初形成的重排产物可以参与随后的催化循环，导致放大的脱色过程。这种额外的催化途径使我们能够提高我们方法的灵敏度并成功区分胺和硫醇。此外，已设计出表现出强分析物诱导荧光调制的探针，以通过使用更灵敏的读数进一步降低检测限。优化的 DAE 探针是未来可编程传感材料和设备的有前途的分子组件。
• [EN] BICYCLIC INDOLE-PYRIMIDINE PI3K INHIBITOR COMPOUNDS SELECTIVE FOR P110 DELTA, AND METHODS OF USE<br/>[FR] COMPOSÉS BICYCLIQUES INDOLE-PYRIMIDINE INHIBITEURS DE PI3K SÉLECTIFS POUR P110 DELTA ET LEURS PROCÉDÉS D'UTILISATION
  申请人：HOFFMANN LA ROCHE

  公开号：WO2010136491A1

  公开（公告）日：2010-12-02

  Formula I (Ia and Ib) compounds wherein (i) X1 is N and X2 is S, (ii) X1 is CR7 and X2 is S, (iii) X1 is N and X2 is NR2, (iv) X1 is CR7 and X2 is O, or (v) X1 is CR7 and X2 is NR2, including stereoisomers, tautomers, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting the delta isoform of PBK, and for treating disorders mediated by lipid kinases such as inflammation, immunological, and cancer. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.

  Formula I（Ia和Ib）化合物，其中（i）X1为N且X2为S，（ii）X1为CR7且X2为S，（iii）X1为N且X2为NR2，（iv）X1为CR7且X2为O，或（v）X1为CR7且X2为NR2，包括立体异构体、互变异构体、代谢物及其药学上可接受的盐，用于抑制PBK的δ同工酶，并用于治疗由脂质激酶介导的疾病，如炎症、免疫和癌症。公开了使用Formula I化合物进行体外、体内和体内诊断、预防或治疗哺乳动物细胞中的这些疾病，或相关病理条件的方法。
• COLD MENTHOL RECEPTOR-1 ANTAGONISTS
  申请人：Colburn Raymond W.

  公开号：US20120053347A1

  公开（公告）日：2012-03-01

  The invention is directed to TRPM8 antagonists of Formula (I). More specifically, the present invention relates to certain novel compounds, methods for preparing compounds, compositions, intermediates and derivatives thereof and methods for treating TRPM8-mediated disorders. Pharmaceutical and veterinary compositions and methods of treating pain and various other disease states or conditions using compounds of the invention are also described.

  这项发明涉及式(I)的TRPM8拮抗剂。更具体地，本发明涉及某些新颖化合物，制备化合物的方法，组合物，中间体及其衍生物，以及治疗TRPM8介导的疾病的方法。还描述了使用本发明化合物治疗疼痛和各种其他疾病状态或病情的药用和兽医组合物及治疗方法。
• Zirconium-redox-shuttled cross-electrophile coupling of aromatic and heteroaromatic halides
  作者：Ting-Feng Wu、Yue-Jiao Zhang、Yue Fu、Fang-Jie Liu、Jian-Tao Tang、Peng Liu、F. Dean Toste、Baihua Ye

  DOI：10.1016/j.chempr.2021.06.007

  日期：2021.7

  palladium-catalyzed processes. The zirconaaziridine-mediated palladium (ZAPd)-catalyzed reaction shows excellent compatibility with various functional groups and diverse heteroaromatic scaffolds. In accord with density functional theory (DFT) calculations, a redox transmetallation between the oxidative addition product and the zirconaaziridine is proposed as the crucial elementary step. Thus, cross-coupling selectivity

  过渡金属催化的交叉亲电偶联 (XEC) 是锻造 C(sp 2 )–C(sp 2 ) 的有力工具) 联芳基分子中来自丰富芳族卤化物的键。虽然通过多金属 XEC 合成不对称联芳基化合物具有很高的合成价值，但两种杂芳族卤化物的选择性 XEC 仍然难以捉摸且具有挑战性。在这里，我们报告了一种均相 XEC 方法，该方法依赖于锆氮丙啶配合物作为双钯催化过程的穿梭。锆氮丙啶介导的钯 (ZAPd) 催化反应显示出与各种官能团和各种杂芳族支架的良好相容性。根据密度泛函理论 (DFT) 计算，氧化加成产物和锆氮丙啶之间的氧化还原金属转移被认为是关键的基本步骤。因此，使用单一过渡金属催化剂的交叉偶联选择性由 Pd(0) 氧化加成到芳族卤化物的相对速率控制。总体而言，组合还原剂和金属转移剂的概念为过渡金属还原偶联催化的发展提供了机会。
• Double Cyclization of Bis(α-hetarylmethyl)amino Esters to Optically Active Bridged N-Heterocycles of HIV-Inhibiting Activity
  作者：Heike Faltz、Christoph Bender、Birgitta M. Wöhrl、Karin Vogel-Bachmayr、Ullrich Hübscher、Kristijan Ramadan、Jürgen Liebscher

  DOI：10.1002/ejoc.200400136

  日期：2004.8

  were synthesized by several routes starting from natural α-amino esters 2 and o-haloaryl- or o-bromohetarylmethyl bromides 1. N-Alkylation of the starting amino esters to 5 and 3 was followed by halogen/lithium exchange and double cyclization. The cyclization products 6 exhibit interesting inhibition of RNase H and DNA-polymerase activity of reverse transcriptase (RT) of HIV-1 at concentrations where

  从天然α-氨基酯2和邻-卤代芳基-或邻-溴代杂芳基甲基溴化物1开始，通过多种途径合成了1-氮杂双环[3.3.1]壬烷6。然后将起始氨基酯N-烷基化为5和3通过卤素/锂交换和双环化。在人类细胞 DNA 聚合酶不受影响的浓度下，环化产物 6 表现出对 RNase H 和 HIV-1 逆转录酶 (RT) 的 DNA 聚合酶活性的有趣抑制。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2004)